Clinical trial
Behavioral Change Following Culturally Informed Biomarker Disclosure in Alzheimer's Disease
NCT05584241 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Behavioral Change Following Culturally Informed Biomarker Disclosure in Alzheimer's Disease
- Lead sponsor
- University of Michigan
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 20, 2023
- Completion date
- May 21, 2026
- Enrollment
- 102 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, amnestic mild cognitive disorder, mild cognitive impairment